IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages

American Journal of Pathology

Volumn 186, Issue 1, 2016, Pages 159-171

  Hos, Deniz ^a   Bucher, Franziska ^a   Regenfuss, Birgit ^a   Dreisow, Marie Luise ^a   Bock, Felix ^a   Heindl, Ludwig M ^a   Eming, Sabine A ^a   Cursiefen, Claus ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; VASCULOTROPIN C;

ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CORNEA NEOVASCULARIZATION; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INFLAMMATION; KERATITIS; KNOCKOUT MOUSE; LYMPHANGIOGENESIS; MACROPHAGE; MOUSE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-10; KERATITIS; LYMPHANGIOGENESIS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84955509507     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.09.012     Document Type: Article

References (61)

1. T. Tammela, and K. Alitalo Lymphangiogenesis: molecular mechanisms and future promise Cell 140 2010 460 476
2. K. Alitalo, T. Tammela, and T.V. Petrova Lymphangiogenesis in development and human disease Nature 438 2005 946 953
3. K. Alitalo The lymphatic vasculature in disease Nat Med 17 2011 1371 1380
4. C. Cursiefen Immune privilege and angiogenic privilege of the cornea Chem Immunol Allergy 92 2007 50 57
5. C. Cursiefen, L. Chen, M.R. Dana, and J.W. Streilein Corneal lymphangiogenesis: evidence, mechanisms, and implications for corneal transplant immunology Cornea 22 2003 273 281
6. R.J. Albuquerque, T. Hayashi, W.G. Cho, M.E. Kleinman, S. Dridi, A. Takeda, J.Z. Baffi, K. Yamada, H. Kaneko, M.G. Green, J. Chappell, J. Wilting, H.A. Weich, S. Yamagami, S. Amano, N. Mizuki, J.S. Alexander, M.L. Peterson, R.A. Brekken, M. Hirashima, S. Capoor, T. Usui, B.K. Ambati, and J. Ambati Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth Nat Med 15 2009 1023 1030
7. B.K. Ambati, M. Nozaki, N. Singh, A. Takeda, P.D. Jani, T. Suthar, and et al. Corneal avascularity is due to soluble VEGF receptor-1 Nature 443 2006 993 997
8. C. Cursiefen, L. Chen, M. Saint-Geniez, P. Hamrah, Y. Jin, S. Rashid, B. Pytowski, K. Persaud, Y. Wu, J.W. Streilein, and R. Dana Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision Proc Natl Acad Sci U S A 103 2006 11405 11410
9. C. Cursiefen, K. Maruyama, F. Bock, D. Saban, Z. Sadrai, J. Lawler, R. Dana, and S. Masli Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes J Exp Med 208 2011 1083 1092
10. N. Singh, M. Tiem, R. Watkins, Y.K. Cho, Y. Wang, T. Olsen, H. Uehara, C. Mamalis, L. Luo, Z. Oakey, and B.K. Ambati Soluble vascular endothelial growth factor receptor-3 is essential for corneal alymphaticity Blood 121 2013 4242 4249
11. C. Cursiefen, L. Chen, L.P. Borges, D. Jackson, J. Cao, C. Radziejewski, P.A. D'Amore, M.R. Dana, S.J. Wiegand, and J.W. Streilein VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment J Clin Invest 113 2004 1040 1050
12. K. Maruyama, M. Ii, C. Cursiefen, D.G. Jackson, H. Keino, M. Tomita, N. Van Rooijen, H. Takenaka, P.A. D'Amore, J. Stein-Streilein, D.W. Losordo, and J.W. Streilein Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages J Clin Invest 115 2005 2363 2372
13. S. Gordon, and P.R. Taylor Monocyte and macrophage heterogeneity Nat Rev Immunol 5 2005 953 964
14. A. Sica, and A. Mantovani Macrophage plasticity and polarization: in vivo veritas J Clin Invest 122 2012 787 795
15. S. Gordon, and F.O. Martinez Alternative activation of macrophages: mechanism and functions Immunity 32 2010 593 604
16. S. Willenborg, T. Lucas, G. van Loo, J.A. Knipper, T. Krieg, I. Haase, B. Brachvogel, M. Hammerschmidt, A. Nagy, N. Ferrara, M. Pasparakis, and S.A. Eming CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair Blood 120 2012 613 625
17. F.O. Martinez, and S. Gordon The M1 and M2 paradigm of macrophage activation: time for reassessment F1000Prime Rep 6 2014 13
18. P.J. Murray, J.E. Allen, S.K. Biswas, E.A. Fisher, D.W. Gilroy, S. Goerdt, S. Gordon, J.A. Hamilton, L.B. Ivashkiv, T. Lawrence, M. Locati, A. Mantovani, F.O. Martinez, J.L. Mege, D.M. Mosser, G. Natoli, J.P. Saeij, J.L. Schultze, K.A. Shirey, A. Sica, J. Suttles, I. Udalova, J.A. van Ginderachter, S.N. Vogel, and T.A. Wynn Macrophage activation and polarization: nomenclature and experimental guidelines Immunity 41 2014 14 20
19. T. Dietrich, F. Bock, D. Yuen, D. Hos, B.O. Bachmann, G. Zahn, S. Wiegand, L. Chen, and C. Cursiefen Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation J Immunol 184 2010 535 539
20. S. Goyal, S.K. Chauhan, J. El Annan, N. Nallasamy, Q. Zhang, and R. Dana Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity? Arch Ophthalmol 128 2010 819 824
21. D. Hos, and C. Cursiefen Lymphatic vessels in the development of tissue and organ rejection Adv Anat Embryol Cell Biol 214 2014 119 141
22. G. Oliver, and M. Detmar The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature Genes Dev 16 2002 773 783
23. R. Huggenberger, S.S. Siddiqui, D. Brander, S. Ullmann, K. Zimmermann, M. Antsiferova, S. Werner, K. Alitalo, and M. Detmar An important role of lymphatic vessel activation in limiting acute inflammation Blood 117 2011 4667 4678
24. R. Huggenberger, S. Ullmann, S.T. Proulx, B. Pytowski, K. Alitalo, and M. Detmar Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation J Exp Med 207 2010 2255 2269
25. E.S. Chung, S.K. Chauhan, Y. Jin, S. Nakao, A. Hafezi-Moghadam, N. van Rooijen, Q. Zhang, L. Chen, and R. Dana Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands Am J Pathol 175 2009 1984 1992
26. S.K. Chauhan, Y. Jin, S. Goyal, H.S. Lee, T.A. Fuchsluger, H.K. Lee, and R. Dana A novel pro-lymphangiogenic function for Th17/IL-17 Blood 118 2011 4630 4634
27. K.M. Bryant-Hudson, H.R. Gurung, M. Zheng, and D.J. Carr Tumor necrosis factor alpha and interleukin-6 facilitate corneal lymphangiogenesis in response to herpes simplex virus 1 infection J Virol 88 2014 14451 14457
28. K.W. Moore, R. de Waal Malefyt, R.L. Coffman, and A. O'Garra Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 2001 683 765
29. F.O. Martinez, A. Sica, A. Mantovani, and M. Locati Macrophage activation and polarization Front Biosci 13 2008 453 461
30. M.E. Stearns, F.U. Garcia, K. Fudge, J. Rhim, and M. Wang Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice Clin Cancer Res 5 1999 711 720
31. J.S. Silvestre, Z. Mallat, M. Duriez, R. Tamarat, M.F. Bureau, D. Scherman, N. Duverger, D. Branellec, A. Tedgui, and B.I. Levy Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb Circ Res 87 2000 448 452
32. H. Hatanaka, Y. Abe, M. Naruke, T. Tokunaga, Y. Oshika, T. Kawakami, H. Osada, J. Nagata, J. Kamochi, T. Tsuchida, H. Kijima, H. Yamazaki, H. Inoue, Y. Ueyama, and M. Nakamura Significant correlation between interleukin 10 expression and vascularization through angiopoietin/TIE2 networks in non-small cell lung cancer Clin Cancer Res 7 2001 1287 1292
33. B. Samolov, A. Kvanta, and I. van der Ploeg Delayed neovascularization in inflammation-induced corneal neovascularization in interleukin-10-deficient mice Acta Ophthalmol 88 2010 251 256
34. K. Takeda, B.E. Clausen, T. Kaisho, T. Tsujimura, N. Terada, I. Forster, and S. Akira Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils Immunity 10 1999 39 49
35. K. Takeda, T. Kaisho, N. Yoshida, J. Takeda, T. Kishimoto, and S. Akira Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice J Immunol 161 1998 4652 4660
36. D. Hos, B. Regenfuss, F. Bock, J. Onderka, and C. Cursiefen Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis Invest Ophthalmol Vis Sci 52 2011 5778 5785
37. D. Hos, S.L. Schlereth, F. Bock, L.M. Heindl, and C. Cursiefen Antilymphangiogenic therapy to promote transplant survival and to reduce cancer metastasis: what can we learn from the eye? Semin Cell Dev Biol 38 2014 117 130
38. C. Cursiefen, K. Maruyama, D.G. Jackson, J.W. Streilein, and F.E. Kruse Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation Cornea 25 2006 443 447
39. D. Hos, D.R. Saban, F. Bock, B. Regenfuss, J. Onderka, S. Masli, and C. Cursiefen Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids Arch Ophthalmol 129 2011 445 452
40. M. Takeuchi, P. Alard, and J.W. Streilein TGF-beta promotes immune deviation by altering accessory signals of antigen-presenting cells J Immunol 160 1998 1589 1597
41. D. Hos, K.R. Koch, F. Bucher, F. Bock, C. Cursiefen, and L.M. Heindl Serum eyedrops antagonize the anti(lymph)angiogenic effects of bevacizumab in vitro and in vivo Invest Ophthalmol Vis Sci 54 2013 6133 6142
42. F. Bock, J. Onderka, D. Hos, F. Horn, P. Martus, and C. Cursiefen Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts Exp Eye Res 87 2008 462 470
43. C.H. Cho, Y.J. Koh, J. Han, H.K. Sung, H. Jong Lee, T. Morisada, R.A. Schwendener, R.A. Brekken, G. Kang, Y. Oike, T.S. Choi, T. Suda, O.J. Yoo, and G.Y. Koh Angiogenic role of LYVE-1-positive macrophages in adipose tissue Circ Res 100 2007 e47 e57
44. G. Jurisic, J.P. Sundberg, and M. Detmar Blockade of VEGF receptor-3 aggravates inflammatory bowel disease and lymphatic vessel enlargement Inflamm Bowel Dis 19 2013 1983 1989
45. R. Guo, Q. Zhou, S.T. Proulx, R. Wood, R.C. Ji, C.T. Ritchlin, B. Pytowski, Z. Zhu, Y.J. Wang, E.M. Schwarz, and L. Xing Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis Arthritis Rheum 60 2009 2666 2676
46. C. Niemand, A. Nimmesgern, S. Haan, P. Fischer, F. Schaper, R. Rossaint, P.C. Heinrich, and G. Muller-Newen Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3 J Immunol 170 2003 3263 3272
47. R. de Waal Malefyt, J. Abrams, B. Bennett, C.G. Figdor, and J.E. de Vries Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes J Exp Med 174 1991 1209 1220
48. D.F. Fiorentino, A. Zlotnik, T.R. Mosmann, M. Howard, and A. O'Garra IL-10 inhibits cytokine production by activated macrophages J Immunol 147 1991 3815 3822
49. C. Buechler, M. Ritter, E. Orsó, T. Langmann, J. Klucken, and G. Schmitz Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli J Leukoc Biol 67 2000 97 103
50. D. Kerjaschki, N. Huttary, I. Raab, H. Regele, K. Bojarski-Nagy, G. Bartel, S.M. Krober, H. Greinix, A. Rosenmaier, F. Karlhofer, N. Wick, and P.R. Mazal Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants Nat Med 12 2006 230 234
51. S. Banerji, J. Ni, S.X. Wang, S. Clasper, J. Su, R. Tammi, M. Jones, and D.G. Jackson LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan J Cell Biol 144 1999 789 801
52. G. Varga, J. Ehrchen, A. Tsianakas, K. Tenbrock, A. Rattenholl, S. Seeliger, M. Mack, J. Roth, and C. Sunderkoetter Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells J Leukoc Biol 84 2008 644 650
53. D.Y. Vogel, P.D. Heijnen, M. Breur, H.E. de Vries, A.T. Tool, S. Amor, and C.D. Dijkstra Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation J Neuroinflammation 11 2014 23
54. N. Platonova, G. Miquel, B. Regenfuss, S. Taouji, C. Cursiefen, E. Chevet, and A. Bikfalvi Evidence for the interaction of fibroblast growth factor-2 with the lymphatic endothelial cell marker LYVE-1 Blood 121 2013 1229 1237
55. H. Kubo, R. Cao, E. Brakenhielm, T. Makinen, Y. Cao, and K. Alitalo Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea Proc Natl Acad Sci U S A 99 2002 8868 8873
56. A.R. Pinto, R. Paolicelli, E. Salimova, J. Gospocic, E. Slonimsky, D. Bilbao-Cortes, J.W. Godwin, and N.A. Rosenthal An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile PLoS One 7 2012 e36814
57. K. Schledzewski, M. Falkowski, G. Moldenhauer, P. Metharom, J. Kzhyshkowska, R. Ganss, A. Demory, B. Falkowska-Hansen, H. Kurzen, S. Ugurel, G. Geginat, B. Arnold, and S. Goerdt Lymphatic endothelium-specific hyaluronan receptor LYVE-1 is expressed by stabilin-1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in bone marrow cultures in vitro: implications for the assessment of lymphangiogenesis J Pathol 209 2006 67 77
58. H. Xu, M. Chen, D.M. Reid, and J.V. Forrester LYVE-1-positive macrophages are present in normal murine eyes Invest Ophthalmol Vis Sci 48 2007 2162 2171
59. M.R. Dana Angiogenesis and lymphangiogenesis: implications for corneal immunity Semin Ophthalmol 21 2006 19 22
60. F. Bock, K. Maruyama, B. Regenfuss, D. Hos, P. Steven, L.M. Heindl, and C. Cursiefen Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases Prog Retin Eye Res 34 2013 89 124
61. S. D'Alessio, C. Correale, C. Tacconi, A. Gandelli, G. Pietrogrande, S. Vetrano, M. Genua, V. Arena, A. Spinelli, L. Peyrin-Biroulet, C. Fiocchi, and S. Danese VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease J Clin Invest 124 2014 3863 3878